24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
70.73% |
|
EBOLA |
12.2% |
|
ENZYME DYNAMICS |
9.76% |
|
ATWRI1 MUTANT SCREENING |
7.32% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
52.63% |
|
ALZHEIMERS |
40.35% |
|
EBOLA |
4.39% |
|
ATWRI1 MUTANT SCREENING |
2.63% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
56.7% |
|
INFLUENZA |
11.05% |
|
CANCER |
9.77% |
|
ENZYME DYNAMICS |
7.79% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
5.82% |
|
RCA STABILITY SIMULATIONS |
2.97% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
1.63% |
|
MEMBRANE TRANSPORT |
1.04% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
1.01% |
|
ATSTP10 SUCROSE TRANSPORT |
.73% |
|
ATSTP10 TRANSPORT SIMULATION |
.53% |
|
RCA OLIGOMERIC STABILITY HEAT STRESS SIMULATIONS |
.48% |
|
SUCROSE TRANSPORTER ATSUC1 |
.34% |
|
EBOLA |
.09% |
|
ATWRI1 MUTANT SCREENING |
.05% |